Fortress Biotech, Inc. ( FBIO) - Key Metrics
FBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.59 | -$0.01 | -$1.87 | -$1.87 |
| 2026Q1 | $0.51 | $3.50 | $6.46 | $6.46 |
| 2025Q4 | $0.58 | -$0.14 | -$0.45 | -$0.45 |
| 2025Q3 | $0.65 | $0.21 | -$0.22 | -$0.22 |
| 2025Q2 | $0.61 | $0.58 | -$1.03 | -$1.03 |
FBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.65 |
| 2026Q1 | 0% | 0.20 |
| 2025Q4 | -4.22% | -4.16 |
| 2025Q3 | 2.84% | 7.12 |
| 2025Q2 | 1.07% | 0.93 |
FBIO
Price: $1.87
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.68 USD
P/E Ratio: 1.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 340489
Ebitda: -32.4 millionMarket Capitalization: 67.4 million